Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1126 | 1033 | 1166 | 1193 | 1345 | - |
Fund Return | 12.65% | 3.34% | 16.61% | 6.05% | 6.11% | - |
Place in category | 23 | 59 | 19 | 11 | 18 | - |
% in Category | 30 | 68 | 22 | 22 | 52 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIFM China Emerging Power Class A | 5.06B | 14.32 | -14.73 | 11.74 | ||
CIFM China Emerging Power Class H | 5.06B | 14.30 | -14.75 | - | ||
CIFM Technology Qian Yan Alloc | 2.86B | 7.23 | -15.53 | - | ||
China Intl AsiaPacific Advantage St | 2.67B | 9.15 | 0.74 | 4.96 | ||
China International China Advanced | 2.47B | 12.72 | -14.12 | 8.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 2.31B | 27.11 | 10.27 | - | ||
E Fund Global Medical Industry CNY | 1.16B | -7.95 | -18.68 | - | ||
006308 | 733.33M | 10.53 | -1.52 | - | ||
006309 | 733.33M | 9.53 | -2.49 | - | ||
CIFM China Biomedicine Alloc | 464.3M | -11.25 | -24.28 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
JPM Global Select Equity I (acc) - EUR | - | 18.78 | - | - | |
JPMorgan Funds - US Equity All Cap Fund C acc - US | LU1033934347 | 11.59 | 345.600 | -0.53% | |
JPMorgan Funds - US Growth Fund I acc - USD | LU0248059726 | 10.23 | 615.690 | +0.32% | |
JPMorgan SAR Global Bond C | HK0000271061 | 8.06 | - | - | |
JPMorgan Funds Global Corporate Bond Fund I (acc | LU0408847183 | 7.38 | 139.040 | -0.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Neutral | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review